News and events
Press releases
Nicox: 2022 Ordinary Shareholder Meeting
Nicox at ARVO 2022: Presentation of clinical Phase 2 results on NCX 4251 and new non-clinical evidence of improved hemodynamic and retinal cell physiology on NCX 470
Nicox Reports 2021 Financial Results and First Quarter 2022 Financial Highlights and Provides Update on Key Programs and Milestones
Nicox’s NCX 470 Dolomites Phase 2 Results Published in Journal of Glaucoma
Nicox’s Partner Fera Pharmaceuticals Obtains Orphan Drug Designation from the U.S. FDA for Naproxcinod for the Treatment of Sickle Cell Disease
Events and conferences
Glaucoma 360
February 10-12, 2022
|
San Francisco, CA, U.S.
https://www.glaucoma.org/news/events/glaucoma-360.php
https://www.glaucoma.org/news/events/glaucoma-360.php
American Glaucoma Society (AGS) 2022 Annual Meeting
March 3-6, 2022
|
Nashville, TN, U.S
https://www.americanglaucomasociety.net/ags-events/annual-meeting
https://www.americanglaucomasociety.net/ags-events/annual-meeting
BIOMED Event
March 8, 2022
|
Paris, France
http://biomedtechevent.com/
http://biomedtechevent.com/
SmallCap Event
April 4-5, 2022
|
Paris, France
Invest Access Event
April 4-5, 2022
|
Paris, France
Association for Research in Vision and Ophthalmology (ARVO) 2022 Annual meeting
May 1-5, 2022 , Denver, CA, U.S. – May 11-12, 2022 – Virtual
https://www.arvo.org/annual-meeting/
https://www.arvo.org/annual-meeting/
H.C. Wainwright Global Investment Conference – May 23-25, 2022 – Miami, Florida, U.S – Hybrid conference
May 23-25, 2022
|
Miami, Florida, U.S
https://hcwevents.com/globalconference/
https://hcwevents.com/globalconference/
15th European Glaucoma Society (EGS) Congress
June 4-8, 2022
|
Athens, Greece
https://egs2022.org/
https://egs2022.org/
BIO International Convention
June 13-16, 2022
|
San Diego, U.S.
https://www.bio.org/events/bio-international-convention
https://www.bio.org/events/bio-international-convention
Spring Midcap Event
June 23-24, 2022
|
Paris, France